Comparison of olanzapine versus quetiapine in the treatment of hospitalized patients with schizophrenia

被引:5
|
作者
Wang, PF
Zhao, Z
机构
[1] Premier Inc, Charlotte, NC USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
关键词
D O I
10.1016/S1098-3015(10)64236-2
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:355 / 355
页数:1
相关论文
共 50 条
  • [1] Quetiapine versus olanzapine for the treatment of negative symptoms in patients with schizophrenia
    Sirota, Pinkhas
    Pannet, Irit
    Koren, Ady
    Tchernichovsky, Eieonora
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2006, 21 (04) : 227 - 234
  • [2] Comparison of quetiapine, olanzapine, and risperidone in schizophrenia
    Sacchetti, E
    Valsecchi, P
    Regini, C
    Galluzzo, A
    Cacciani, P
    Agrimi, E
    Mencacci, C
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S286 - S286
  • [3] A comparison of the effects of quetiapine and olanzapine on glucose metabolism in patients with schizophrenia
    Henderson, D
    Copeland, PM
    Borba, CP
    Nguyen, DD
    Evins, AE
    Zhang, H
    Hayden, D
    Freudenreich, O
    Cather, C
    Schoenfeld, D
    Goff, DC
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S494 - S495
  • [4] The effectiveness of quetiapine versus olanzapine in improving negative symptoms of patients with schizophrenia
    Sirota, P
    Tchernichowsky, E
    Panet, I
    Koren, A
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 170 - 170
  • [5] The comparison of risperidone, olanzapine and quetiapine in the treatment of chronic schizophrenia and schizoaffective disorder
    Kim, JG
    Cho, DH
    Choi, HK
    Kim, HJ
    Cho, JH
    Kang, SH
    Lee, SJ
    Lee, JG
    Kim, HT
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S245 - S245
  • [6] Comparison of quetiapine ('Seroquel'), olanzapine, and risperidone in a randomized study in patients with schizophrenia
    Sacchetti, E
    Valseechi, P
    Regini, C
    Galluzzo, A
    Cacciani, P
    Agrimi, E
    Mencacci, C
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S413 - S413
  • [7] Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia
    Michael Riedel
    Norbert Müller
    Ilja Spellmann
    Rolf R. Engel
    Richard Musil
    Rosamaria Valdevit
    Sandra Dehning
    Anette Douhet
    Anja Cerovecki
    Martin Strassnig
    Hans-Jürgen Möller
    [J]. European Archives of Psychiatry and Clinical Neuroscience, 2007, 257 : 402 - 412
  • [8] Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia
    Riedel, Michael
    Mueller, Norbert
    Spellmann, Ilja
    Engel, Rolf R.
    Musil, Richard
    Valdevit, Rosamaria
    Dehning, Sandra
    Douhet, Anette
    Cerovecki, Anja
    Strassnig, Martin
    Moeller, Hans-Juergen
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2007, 257 (07) : 402 - 412
  • [9] Resource Utilization and Costs of Schizophrenia Patients Treated with Olanzapine versus Quetiapine in a Medicaid Population
    Yu, Andrew P.
    Atanasov, Pavel
    Ben-Hamadi, Rym
    Birnbaum, Howard
    Stensland, Michael D.
    Philips, Glenn
    [J]. VALUE IN HEALTH, 2009, 12 (05) : 708 - 715
  • [10] An economic comparison of olanzapine versus haloperidol in the treatment of schizophrenia in France
    Gregor, KJ
    Allicar, MP
    Lilliu, H
    Bouhassira, M
    Le Pen, C
    [J]. SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 189 - 190